ARC and neoplasm: Considering that the bone-tumor niche can further promote the spread of cancer cells to other organs and tissues58–62, we therefore assessed anti-metastatic activity of BP-αCD3-αEGFR-ARC Exos in mice bearing tumors derived from highly aggressive and invasive MDA-MB-231 cells.